Article

Report – Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic disease

2022-10-13

Abstract excerpt

Payer coverage for Exome Sequencing (ES) is becoming commonplace (albeit in some cases with prior authorization restrictions), coverage for Genome Sequencing (GS) is rare, with most payers considering it as investigational and not medically necessary. Previous studies had identified several concerns and challenges from the payer perspective. The objective of this study is to conduct a targeted literature review o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30b4a020-7e51-5d31-be59-5e4c0b2fc749
DOI: 10.1101/2022.10.10.22280925

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Report – Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic diseaseDOI 10.1101/2022.10.10.22280925Read

Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseasesSemantic proximity Read

A meta-analysis of the diagnostic sensitivity and clinical utility of genome sequencing, exome sequencing and chromosomal microarray in children with suspected genetic diseasesSemantic proximity Read

Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditionsSemantic proximity Read

Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center’s ExperienceSemantic proximity Read

Diagnostic Yield of Genome Sequencing Versus Exome Sequencing in Pediatric Patients With Rare Phenotypes: A Systematic Review and Meta-Analysis.Semantic proximity Read

Rapid Whole Genome Sequencing Decreases Morbidity and Healthcare Cost of Hospitalized InfantsSemantic proximity Read

Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience.Semantic proximity Read

Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disordersSemantic proximity Read

Comparing the diagnostic and clinical utility of WGS and WES with standard genetic testing (SGT) in children with suspected genetic diseases: A systematic review and meta-analysisSemantic proximity Read

Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a reviewSemantic proximity Read

A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurologySemantic proximity Read

The clinical utility of exome and genome sequencing across clinical indications: a systematic review.Semantic proximity Read